Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

NCT00979173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: AC480

Sponsor

Annick Desjardins

Collaborators

[object Object]